Q3 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | OWLET INC | $9,117,548 | – | 2,035,167 | – | 100.00% | – | |
Exit | OWLET INC | $0 | – | -28,492,332 | – | -100.00% | – |
Q2 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | OWLET INC | $9,690,243 | – | 28,492,332 | – | 100.00% | – |
Q4 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LHDX | Exit | LUCIRA HEALTH INC | $0 | – | -6,223,795 | – | -2.46% | – |
Exit | OWLET INC | $0 | – | -28,492,332 | – | -11.38% | – | |
Exit | ENOVIX CORPORATION | $0 | – | -12,583,258 | – | -86.16% | – |
Q3 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | ENOVIX CORPORATION | $230,777,000 | +47.3% | 12,583,258 | -28.4% | 86.16% | +19.2% |
Q2 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | ENOVIX CORPORATION | $156,667,000 | – | 17,583,258 | – | 72.30% | – | |
New | OWLET INC | $48,437,000 | – | 28,492,332 | – | 22.35% | – | |
LHDX | New | LUCIRA HEALTH INC | $11,576,000 | – | 6,223,795 | – | 5.34% | – |